Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yu-Yi Chu
Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-Resistance With Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder
Clinical Cancer Research
Cancer Research
Oncology
Related publications
A Case of Nested Variant of Urothelial Carcinoma of the Urinary Bladder
The Journal of the Japanese Society of Clinical Cytology
Cadmium in Urothelial Carcinoma of the Bladder
Polish Journal of Pathology
Medicine
Forensic Medicine
Pathology
Efficacy of Neoadjuvant Gemcitabine and Cisplatin in the Management of Muscle-Invasive Urothelial Carcinoma of the Bladder
Japanese Journal of Urology
Urology
Imp3 Expression in Urothelial Carcinomas of the Urinary Bladder
Turk Patoloji Dergisi
Forensic Medicine
Pathology
Imp3 Expression in Urothelial Carcinomas of the Urinary Bladder
Turk Patoloji Dergisi
Forensic Medicine
Pathology
CD10 Expression in Urothelial Carcinoma of the Bladder
Diagnostic Pathology
Forensic Medicine
Medicine
Pathology
Histology
Inhibition of RNA-Binding Protein Musashi-1 Suppresses Malignant Properties and Reverses Paclitaxel Resistance in Ovarian Carcinoma
Journal of Cancer
Oncology
Transcriptional Up-Regulation of SOD1 by CEBPD: A Potential Target for Cisplatin Resistant Human Urothelial Carcinoma Cells
Biochemical Pharmacology
Biochemistry
Pharmacology
Phase II Study of Second-Line Chemotherapy With Paclitaxel, Gemcitabine, and Cisplatin for Advanced Urothelial Carcinoma
Anticancer Research
Medicine
Cancer Research
Oncology